Founding Sponsors Exit Sotera Health with 31.8M Share Secondary Offering

summarizeSummary

Sotera Health's founding sponsors, Warburg Pincus and GTCR, are selling their remaining 31.8 million shares in a secondary offering, marking their complete exit from the company and the termination of their special governance rights.

check_boxKey Events

• Major Secondary Offering

  Affiliates of Warburg Pincus and GTCR are offering 31,838,253 shares of common stock, valued at approximately $502.4 million based on the last reported share price in the filing ($15.78).

• Founding Sponsors' Complete Exit

  Following this offering, the founding sponsors (Warburg Pincus and GTCR) are expected to no longer hold any shares and their special corporate governance rights, including director designation, will terminate.

• No Proceeds to Company

  Sotera Health Company will not receive any proceeds from the sale of shares by the selling stockholders.

• Shift in Ownership Structure

  This transaction represents a significant change in the company's ownership and governance, as major institutional investors fully divest their stake.

auto_awesomeAnalysis

This preliminary prospectus supplement details a significant secondary offering where founding sponsors, Warburg Pincus and GTCR affiliates, are selling their remaining 31,838,253 shares of common stock. This transaction marks their complete exit from Sotera Health and the termination of their special corporate governance rights, including the ability to designate directors. The company will not receive any proceeds from this sale. This offering, valued at approximately $502.4 million based on the last reported share price in the filing, represents a substantial portion of the company's market capitalization and follows a pattern of distribution by these sponsors in recent months. The full exit of major institutional investors can create a significant overhang on the stock and signals a fundamental shift in the company's ownership and governance structure.